Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


SVB Leerink Maintains Market Perform on Abiomed, Raises Price Target to $375


Benzinga | Aug 6, 2021 05:53AM EDT

SVB Leerink Maintains Market Perform on Abiomed, Raises Price Target to $375

SVB Leerink analyst Danielle Antalffy maintains Abiomed (NASDAQ:ABMD) with a Market Perform and raises the price target from $335 to $375.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC